Article info
PDFRheumatoid arthritis
Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial
- Correspondence to Renske CF Hebing, Reade, Amsterdam Rheumatology and Immunology Center, Amsterdam 1056AA, Netherlands; r.hebing{at}reade.nl
Citation
Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial
Publication history
- Received September 25, 2022
- Accepted November 21, 2022
- First published December 21, 2022.
Online issue publication
March 10, 2023
Article Versions
- Previous version (21 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.